|Min SIP Amount||₹1000|
|NAV||₹13.16 (02 Mar 2021)|
|Fund Started||06 Nov 2020|
|Fund Size||₹13 Cr|
|Fortis Healthcare (India) Ltd||Healthcare||Equity||8.8%|
|HCL Technologies Ltd.||Technology||Equity||8.3%|
|Tata Elxsi Ltd.||Technology||Equity||7.2%|
|Adani Ports and Special Economic Zone Ltd.||Services||Equity||7.1%|
|Sun Pharmaceutical Inds. Ltd.||Healthcare||Equity||6.9%|
|Divi's Laboratories Ltd.||Healthcare||Equity||6.6%|
|Tech Mahindra Ltd.||Technology||Equity||6.2%|
|Bharti Airtel Ltd.||Communication||Equity||6.1%|
|Alembic Pharmaceuticals Ltd.||Healthcare||Equity||5.9%|
Quant ESG Equity Fund Direct Growth is a Equity Mutual Fund Scheme launched by Quant Mutual Fund. This scheme was made available to investors on 06 Nov 2020. Sanjeev Sharma is the Current Fund Manager of Quant ESG Equity Fund Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹13 Cr and the Latest NAV as of 02 Mar 2021 is ₹13.16.
The Quant ESG Equity Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to 1000. Minimum Lumpsum Investment is 5000. Exit load of 1%, if redeemed within 1 year.
The scheme seeks to generate long term capital appreciation by investing in a diversified portfolio of companies demonstrating sustainable practices across Environmental, Social and Governance (ESG) parameters.